US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 2.050
  • -0.130-5.96%
Close Nov 15 16:00 ET
  • 2.050
  • 0.0000.00%
Post 17:13 ET
146.43MMarket Cap-3942P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
189.59%22M
40.34%-12.32M
21.01%-20.82M
-15.92%-78.33M
64.63%-6.76M
-214.15%-24.56M
-5.02%-20.65M
-25.68%-26.35M
-29.60%-67.57M
-11.95%-19.12M
Net income from continuing operations
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
Depreciation and amortization
-18.26%179K
11.01%242K
22.73%243K
8.28%863K
20.00%228K
13.47%219K
5.83%218K
-4.81%198K
-13.65%797K
-3.55%190K
Deferred tax
----
----
----
---367K
----
----
----
----
--0
----
Other non cash items
-52.94%800K
113.33%200K
450.00%2.8M
-672.34%-26.9M
-470.42%-26.3M
-22.73%1.7M
55.88%-1.5M
33.33%-800K
-80.69%4.7M
222.73%7.1M
Change In working capital
909.45%25.6M
-227.37%-4.68M
-104.82%-9.01M
885.69%9.39M
470.47%13.27M
-156.95%-3.16M
898.64%3.68M
-24.42%-4.4M
11.02%-1.2M
-590.37%-3.58M
-Change in receivables
-121.18%-18K
-81.18%48K
62.87%-75K
33.81%186K
-57.52%48K
112.50%85K
6,475.00%255K
-1,920.00%-202K
-6.71%139K
-39.89%113K
-Change in prepaid assets
118.56%1.43M
137.35%273K
333.87%2.04M
42.68%-1.32M
239.92%7.98M
-466.27%-7.69M
-165.21%-731K
-564.89%-874K
59.16%-2.29M
-1.66%-5.7M
-Change in payables and accrued expense
-116.96%-753K
-220.50%-5M
-230.47%-10.98M
995.63%10.52M
161.62%5.25M
30.01%4.44M
654.21%4.15M
10.53%-3.32M
-76.73%960K
-59.08%2.01M
Cash from discontinued investing activities
Operating cash flow
189.59%22M
40.34%-12.32M
21.01%-20.82M
-15.92%-78.33M
64.63%-6.76M
-214.15%-24.56M
-5.02%-20.65M
-25.68%-26.35M
-29.60%-67.57M
-11.95%-19.12M
Investing cash flow
Cash flow from continuing investing activities
-91.41%2.8M
96.57%-674K
-34.75%16.83M
266.01%46.22M
179.42%7.55M
2,573.29%32.53M
7.36%-19.66M
-13.81%25.8M
107.53%12.63M
129.45%2.7M
Net PPE purchase and sale
--0
106.06%14K
75.59%-135K
-116.36%-1.31M
-320.00%-441K
44.00%-84K
-24.19%-231K
-237.20%-553K
-96.43%-605K
47.50%-105K
Net investment purchase and sale
-91.43%2.8M
96.46%-688K
-35.61%16.97M
259.17%47.53M
184.68%7.99M
2,286.10%32.62M
7.63%-19.43M
-12.44%26.35M
107.91%13.23M
131.27%2.81M
Cash from discontinued investing activities
Investing cash flow
-91.41%2.8M
96.57%-674K
-34.75%16.83M
266.01%46.22M
179.42%7.55M
2,573.29%32.53M
7.36%-19.66M
-13.81%25.8M
107.53%12.63M
129.45%2.7M
Financing cash flow
Cash flow from continuing financing activities
125.29%22K
-100.04%-11K
-55K
-63.35%26.71M
32.43%49K
-690.91%-87K
-63.27%26.74M
0
-67.62%72.87M
1,950.00%37K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--0
----
Net common stock issuance
--0
----
----
-63.28%26.71M
--0
--0
----
----
-69.46%72.74M
--0
Proceeds from stock option exercised by employees
113.33%32K
----
----
-40.13%94K
32.43%49K
--15K
----
----
-89.24%157K
--37K
Net other financing activities
---10K
---11K
---55K
-200.00%-102K
--0
----
----
----
98.91%-34K
--0
Cash from discontinued financing activities
Financing cash flow
125.29%22K
-100.04%-11K
---55K
-63.35%26.71M
32.43%49K
-690.91%-87K
-63.27%26.74M
--0
-67.62%72.87M
1,950.00%37K
Net cash flow
Beginning cash position
-26.70%22.83M
-19.86%35.84M
-11.92%39.88M
65.55%45.28M
-36.68%39.04M
-54.37%31.15M
23.06%44.72M
65.55%45.28M
23.96%27.35M
15.02%61.65M
Current changes in cash
214.54%24.82M
4.16%-13.01M
-627.39%-4.04M
-130.11%-5.4M
105.12%838K
219.35%7.89M
-142.52%-13.57M
-106.17%-555K
239.16%17.93M
37.62%-16.38M
End cash Position
22.06%47.65M
-26.70%22.83M
-19.86%35.84M
-11.92%39.88M
-11.92%39.88M
-36.68%39.04M
-54.37%31.15M
23.06%44.72M
65.55%45.28M
65.55%45.28M
Free cash flow
189.28%22M
41.07%-12.31M
22.14%-20.95M
-16.81%-79.63M
62.53%-7.2M
-209.29%-24.64M
-5.20%-20.89M
-27.32%-26.91M
-30.00%-68.17M
-11.26%-19.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 189.59%22M40.34%-12.32M21.01%-20.82M-15.92%-78.33M64.63%-6.76M-214.15%-24.56M-5.02%-20.65M-25.68%-26.35M-29.60%-67.57M-11.95%-19.12M
Net income from continuing operations 74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M
Depreciation and amortization -18.26%179K11.01%242K22.73%243K8.28%863K20.00%228K13.47%219K5.83%218K-4.81%198K-13.65%797K-3.55%190K
Deferred tax ---------------367K------------------0----
Other non cash items -52.94%800K113.33%200K450.00%2.8M-672.34%-26.9M-470.42%-26.3M-22.73%1.7M55.88%-1.5M33.33%-800K-80.69%4.7M222.73%7.1M
Change In working capital 909.45%25.6M-227.37%-4.68M-104.82%-9.01M885.69%9.39M470.47%13.27M-156.95%-3.16M898.64%3.68M-24.42%-4.4M11.02%-1.2M-590.37%-3.58M
-Change in receivables -121.18%-18K-81.18%48K62.87%-75K33.81%186K-57.52%48K112.50%85K6,475.00%255K-1,920.00%-202K-6.71%139K-39.89%113K
-Change in prepaid assets 118.56%1.43M137.35%273K333.87%2.04M42.68%-1.32M239.92%7.98M-466.27%-7.69M-165.21%-731K-564.89%-874K59.16%-2.29M-1.66%-5.7M
-Change in payables and accrued expense -116.96%-753K-220.50%-5M-230.47%-10.98M995.63%10.52M161.62%5.25M30.01%4.44M654.21%4.15M10.53%-3.32M-76.73%960K-59.08%2.01M
Cash from discontinued investing activities
Operating cash flow 189.59%22M40.34%-12.32M21.01%-20.82M-15.92%-78.33M64.63%-6.76M-214.15%-24.56M-5.02%-20.65M-25.68%-26.35M-29.60%-67.57M-11.95%-19.12M
Investing cash flow
Cash flow from continuing investing activities -91.41%2.8M96.57%-674K-34.75%16.83M266.01%46.22M179.42%7.55M2,573.29%32.53M7.36%-19.66M-13.81%25.8M107.53%12.63M129.45%2.7M
Net PPE purchase and sale --0106.06%14K75.59%-135K-116.36%-1.31M-320.00%-441K44.00%-84K-24.19%-231K-237.20%-553K-96.43%-605K47.50%-105K
Net investment purchase and sale -91.43%2.8M96.46%-688K-35.61%16.97M259.17%47.53M184.68%7.99M2,286.10%32.62M7.63%-19.43M-12.44%26.35M107.91%13.23M131.27%2.81M
Cash from discontinued investing activities
Investing cash flow -91.41%2.8M96.57%-674K-34.75%16.83M266.01%46.22M179.42%7.55M2,573.29%32.53M7.36%-19.66M-13.81%25.8M107.53%12.63M129.45%2.7M
Financing cash flow
Cash flow from continuing financing activities 125.29%22K-100.04%-11K-55K-63.35%26.71M32.43%49K-690.91%-87K-63.27%26.74M0-67.62%72.87M1,950.00%37K
Net issuance payments of debt --------------0------------------0----
Net common stock issuance --0---------63.28%26.71M--0--0---------69.46%72.74M--0
Proceeds from stock option exercised by employees 113.33%32K---------40.13%94K32.43%49K--15K---------89.24%157K--37K
Net other financing activities ---10K---11K---55K-200.00%-102K--0------------98.91%-34K--0
Cash from discontinued financing activities
Financing cash flow 125.29%22K-100.04%-11K---55K-63.35%26.71M32.43%49K-690.91%-87K-63.27%26.74M--0-67.62%72.87M1,950.00%37K
Net cash flow
Beginning cash position -26.70%22.83M-19.86%35.84M-11.92%39.88M65.55%45.28M-36.68%39.04M-54.37%31.15M23.06%44.72M65.55%45.28M23.96%27.35M15.02%61.65M
Current changes in cash 214.54%24.82M4.16%-13.01M-627.39%-4.04M-130.11%-5.4M105.12%838K219.35%7.89M-142.52%-13.57M-106.17%-555K239.16%17.93M37.62%-16.38M
End cash Position 22.06%47.65M-26.70%22.83M-19.86%35.84M-11.92%39.88M-11.92%39.88M-36.68%39.04M-54.37%31.15M23.06%44.72M65.55%45.28M65.55%45.28M
Free cash flow 189.28%22M41.07%-12.31M22.14%-20.95M-16.81%-79.63M62.53%-7.2M-209.29%-24.64M-5.20%-20.89M-27.32%-26.91M-30.00%-68.17M-11.26%-19.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data